resorcinol has been researched along with 2-aminopyrimidine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Santos-Martins, D | 1 |
| Ai, J; Geng, K; Geng, M; Ji, Y; Song, Z; Sun, D; Xia, Z; Zhang, A; Zhang, RR | 1 |
2 other study(ies) available for resorcinol and 2-aminopyrimidine
| Article | Year |
|---|---|
Interaction with specific HSP90 residues as a scoring function: validation in the D3R Grand Challenge 2015.
Topics: Binding Sites; Databases, Chemical; Drug Design; HSP90 Heat-Shock Proteins; Humans; Kinetics; Ligands; Molecular Docking Simulation; Protein Binding; Pyrimidines; Resorcinols; Thermodynamics | 2016 |
Discovery of 2,4-diarylaminopyrimidines bearing a resorcinol motif as novel ALK inhibitors to overcome the G1202R resistant mutation.
Topics: Anaplastic Lymphoma Kinase; Apoptosis; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Discovery; Humans; Molecular Docking Simulation; Molecular Structure; Mutation; Protein Kinase Inhibitors; Pyrimidines; Receptor Protein-Tyrosine Kinases; Resorcinols; Structure-Activity Relationship | 2018 |